Could a common drug help stroke patients heal faster?

NCT ID NCT07575984

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a drug called Mexidol in people who have had an ischemic stroke (a stroke caused by a blocked blood vessel in the brain). The goal is to see if Mexidol can reduce the size of the brain injury and improve recovery. The trial will involve 120 adults aged 18 to 90 who are treated within the first few days after their stroke. Participants will receive Mexidol as an IV infusion for 10 days, followed by tablets for 60 days, on top of standard stroke care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Mexidol (ethylmethylhydroxypyridine succinate) given as an IV solution and later as tablets

What this could lead to

If it works, this could point toward a treatment that limits brain damage and improves recovery after an ischemic stroke.

What could go wrong

This is a small, early-phase pilot study (120 people) in Russia, so results may not apply broadly. The drug is already approved for other uses, but its benefit for stroke is unproven, and there is a risk of side effects like bleeding.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral infarction ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • City Hospital № 40 of Kurortny District

    RECRUITING

    Saint Petersburg, 197706, Russia

    Contact

  • First City Clinical Hospital named after E.E. Volosevich

    RECRUITING

    Arkhangelsk, 163000, Russia

    Contact

  • Hospital for War Veterans

    RECRUITING

    Saint Petersburg, 193079, Russia

    Contact

  • Ivanovo Regional Clinical Hospital

    RECRUITING

    Ivanovo, 153040, Russia

    Contact

  • Regional Clinical Hospital

    RECRUITING

    Ryazan, 390039, Russia

    Contact

  • Regional Clinical Hospital

    RECRUITING

    Tver', 170036, Russia

    Contact

  • Regional Clinical Hospital

    RECRUITING

    Yaroslavl, 150062, Russia

    Contact

  • Smolensk Regional Clinical Hospital

    RECRUITING

    Smolensk, 214018, Russia

    Contact

  • Zhukovskiy Regional Clinical Hospital,

    RECRUITING

    Zhukovskiy, 140180, Russia

    Contact